Loading...

BNGO BIONANO GENOMICS INC Disposals and divestitures 8-K Filing

BNN

BNG

BIONANO GENOMICS INC

(BNGO)

2025 8-K

Show Summary

Show Summary

Management Changes

Financial Statements

Earnings Announcement

Stock Offering Agreement

Sales Agreement Termination

Stockholder Meeting

Financial Results

Securities Offering

Share Issuance Approval

Q3 Financial Results

Q3 2024 Results

Cost Reduction Plan

Financial Results

Securities Purchase Agreement

Annual Meeting of Stockholders

Securities Purchase Agreement

Financial Results Q1 2024

Registered Direct Offering

Results of Operations and F...

Securities Purchase Agreeme...

Earnings Reports

Securities Purchase Agreement

Appointment of Chief Financ...

Financial Results

Reverse Stock Split

Equity Offerings

Annual Meeting of Stockholders

Financial Results

Financial Results

Purchase Agreement

Financial Results

Financial Results

Financial Results

External Links:

Bionano Genomics, Inc. is terminating its Sales Agreement with Cowen and Company, which allowed for the sale of up to $200 million in common stock through an equity offering program, effective February 14, 2025.

AI Assistant

BIONANO GENOMICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.